Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.50 -2.78% 87.50 85.00 90.00 90.00 87.50 90.00 15,829 16:11:26
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.7 -9.1 -8.0 - 103

Shield Therapeutics Share Discussion Threads

Showing 5801 to 5825 of 6225 messages
Chat Pages: Latest  237  236  235  234  233  232  231  230  229  228  227  226  Older
DateSubjectAuthorDiscuss
07/5/2020
12:06
Yep, interesting perspective! Seems like share price stuck in a rut atm though.
daveboy1
07/5/2020
10:15
Winding down. Really ?! Is the push in China winding down US deal winding down ! PT20 development winding down ! Covid related delay on paediatrics winding down !? You after some cheaper shares Cranky !
peachie 74
07/5/2020
09:16
I wouldn't spend too much time dissecting these scripted interviews. He even said "readers" when he should have said "viewers". It's just another holding statement. I'm sure he's reasonably competent. Both medical director and CEO have gone. Paediatric study on hold. This company is winding down as a development organisation. Fair enough. They did amazingly well. Tiny slip up at the end.
crankyman
07/5/2020
08:05
I do think they could be a sitting duck for a take-over at these levels. DYOR etc
peachie 74
07/5/2020
07:54
He certainly does but the same can be said for every interview in the last 12months when asked about USA negotiations. A comment which I found interesting and slightly contradictory that he did not know from Nordgine if they had benefited from the current CV19 which if having a good working relation as he said why would communication regarding this not have taken place after 2/3 months of effect they will have to know the answer by now.
best1467
06/5/2020
20:22
Is it me or does he really emphasise ALOT of interest in the US ..?
peachie 74
06/5/2020
15:29
Looks like Shield and the new C/O are on a PR push. Just been sent this by Shield themselves. Good news coming I think. DYOR. GLA
peachie 74
06/5/2020
15:28
https://www.voxmarkets.co.uk/articles/shield-therapeutics-blencowe-resources-and-john-mayor-on-the-markets-commodities-dbf74eb/
peachie 74
05/5/2020
16:00
Looks like the US deal is probably closer than a lot of people think if they've already started packing drugs for US market.
78steve
05/5/2020
15:05
Nice one Nobby. Good confident interview. No mention of Carl, probably at Tims request ! US deal close, (not if, just when) China moving forward, he seemed Bullish to me. All coming together. Good how he saw the obvious gap in the market that could be presented, with patients and clinicians not wanting IV delivery due to virus related issues.
peachie 74
05/5/2020
14:51
Very reassuring interview. Progress is being made on all fronts except maybe the paediatric study which is delayed. The most interesting part to me was they are making and packing some drug ready for the US market. That shows confidence that a deal is not far away.
nobbygnome
05/5/2020
14:36
Proactive interview just out https://www.proactiveinvestors.co.uk/companies/news/918859/shield-therapeutics--very-active--on-us-partnering-discussions-with-significant-interest-918859.html
nobbygnome
05/5/2020
13:34
Didn't one of the directors buy at 178p in the last year so they probably expect a good return on that purchase
78steve
05/5/2020
12:52
Quite good buying interest.
montyhedge
05/5/2020
11:30
Once this gets to 150+ many will probably be topping up at 150+ in anticipation of US deal and targeting 250p on that news. Dyor
78steve
05/5/2020
11:23
MM’s will try all tricks to try and mug a few weak holders but there aren’t many shares in PI’s hands anyway and most are holding, so expect decent moves back to 150-180p area over the quarter & into HY2
ny boy
05/5/2020
11:17
Just tried to get 4K and was offered 125.5p, which I didn't take. The MMs are struggling here...
nobbygnome
05/5/2020
11:17
I'm fully loaded now last top up at 112. Would think not many shares available for PI's to purchase at present
78steve
05/5/2020
10:38
Bought another 1000 shares in my SIPP this morning. Slowly accumulating more after selling a chunk at 160 odd. Can't decide how big to go at present but there is no doubt it is good value at this level.
nobbygnome
05/5/2020
10:36
Should take out the recent high soon imo
ny boy
04/5/2020
21:32
Best. So you are saying sales of 600m+ will justify market cap of 370m?
78steve
04/5/2020
21:12
That valuation is based on peak sales in Eu €130m USA $410m China $126m so its several years down the line. How they can increase the valuation at the moment on the current fundamentals is crazy I’m just been honest it’s laughable and makes no sense. Before I get negative comment I’m a long term holder but these brokers are clueless and have less understanding of the business than some PI in most cases and don’t forget are getting payed handsomely as well.
best1467
04/5/2020
21:00
Good derisked place to put some money.IMHO/DYOR. Covid hasn’t stopped production, and if anything has got to have helped push IV to the side and open up the option for a well tolerated alternative. Just need now Norgine trading update in Europe.. RNS seemed positive in this regard US deal sorting and the massive stability that will bring How the H2H can be used moving forward. Clearly a lot of it can. How China is progressing Etc Seems just positive news flow die IMHO. 180/200 was the price reached after FDA approval and before China etc. So atm a great price I reckon.
peachie 74
04/5/2020
20:16
Reasons to be cheerful going forward then year, stay long, stay patient! Valuation: £369.2m or 315p/share
ny boy
04/5/2020
16:32
Cranky - the £12m for 2020 will include Chinese upfront payment - so c£9m. So royalties c£3m for 2020. Current numbers are slightly irrelevant IMHO. Get the US deal signed and we could start selling in Q3/Q4 - manufacturing has already commenced to complete potential US initial order in Sept 2020. Might also be possible to have limited access to Chinese market for specific conditions - being discussed with regulators i think. The great news is Edison think 315p without US deal. So even at only 50% of this valuation we are c40% undervalued at 115p
shandypants2
Chat Pages: Latest  237  236  235  234  233  232  231  230  229  228  227  226  Older
ADVFN Advertorial
Your Recent History
LSE
STX
Shield The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200712 13:23:15